N
NOVT
Novanta Inc
155.30
+3.87+2.56%Closed19:15 06/18 EDT
OPEN/PREV CLOSE153.72/151.43
TODAY RANGE152.76-157.48
VOL683.64K
MARKET CAP5.53B
52 WEEK RANGE98.27-171.85
AVG VOL (3M)447.72K
% TURNOVER1.92%
TURNOVER0
P/E (TTM)112.05
% RANGE3.11%
EPS(TTM)1.386
P/E(FORWARD)62.49
P/B4.218
BVPS36.82
DIVIDEND--
P/S5.65
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.49B
SHARES OUTSTANDING35.61M
NEXT EARNINGS08/03-08/07
FREE FLOAT35.34M
LOT SIZE1
EX-DATE12/29/2010
News
Press Releases
Financial Reports
Profile
Simply Wall St·3h ago
Novanta (NOVT) Stock Could Be 11.3% Undervalued On Its Acquisition Growth Narrative
Simply Wall St·06/13 01:27
Novanta (NOVT) Stock Valuation Check After Recent Outperformance And Premium P/E Multiple
Seeking Alpha·06/12 15:32
Data Center Boom Fuels Renewables Deals; AI Drives Corporate Venture Investment
Seeking Alpha·06/11 04:22
Novanta: An Interesting Deal Accelerates Growth
Simply Wall St·06/10 08:29
Novanta’s Riverpoint Deal Shifts Focus Toward Recurring Surgical Consumables Revenue
TipRanks·06/09 22:39
Novanta Announces $300 Million Private Share Placement
NASDAQ·06/09 22:21
Broader Market Pressured as Chip Stocks Sink
NASDAQ·06/09 16:59
Stocks Erase Early Gains as Chipmakers Turn Lower
Seeking Alpha·06/09 12:58
4 stocks to watch on Tuesday: JBLU, GSK, PFE, NOVT
TipRanks·06/09 11:26
Novanta price target raised to $180 from $173 at Baird
Seeking Alpha·06/09 11:21
Novanta to acquire Riverpoint Medical in $1.45B deal, raises $300M privately
Dow Jones·06/09 10:46
Novanta Strikes $1.45B Deal for Riverpoint Medical
TipRanks·06/09 10:34
Novanta to Acquire Riverpoint Medical in Strategic Deal
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.